Elena Skillett, NP
Critical Care Medicine · Lincoln, NENPI 1497001473
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 159 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $615 and has fallen 50.1% since, to $307 in 2025.
Across 159 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$518
- Pfizer$508
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$386
- Johnson & Johnson$334
- Abiomed$248
- AstraZeneca$99
- plus $306 from 7 others
What the payments were for
- Food & beverage$2,400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 24 | $518 |
| Pfizer | 26 | $508 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 59 | $386 |
| Johnson & Johnson | 19 | $334 |
| Abiomed | 9 | $248 |
| AstraZeneca | 7 | $99 |
| Novo Nordisk | 3 | $85 |
| Edwards Lifesciences | 3 | $61 |
| Novartis | 3 | $51 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Chiesi USA, Inc. | 2 | $35 |
| Abbott | 1 | $19 |
| Boston Scientific | 1 | $18 |
How this compares
Too few critical care medicine providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $43,841 |
| XareltoRivaroxaban | 38 | $23,911 |
| JardianceEmpagliflozin | 29 | $19,767 |
| BrilintaTicagrelor | 18 | $9,002 |
| Midodrine Hcl | 14 | $3,065 |
| Metoprolol Succinate | 143 | $1,384 |
| ClopidogrelClopidogrel Bisulfate | 224 | $1,069 |
| Atorvastatin Calcium | 141 | $898 |
| Prasugrel Hcl | 29 | $880 |
| Colchicine | 13 | $491 |
| Carvedilol | 76 | $414 |
| Pantoprazole Sodium | 70 | $334 |
| Potassium Chloride | 48 | $290 |
| Amiodarone Hcl | 45 | $224 |
| Amlodipine Besylate | 47 | $186 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $508 | $43,84171 claims |
| Johnson & JohnsonXarelto | $334 | $23,91138 claims |
| Boehringer IngelheimJardiance | $518 | $19,76729 claims |
| AstraZenecaBrilinta | $99 | $9,00218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few critical care medicine providers in Nebraskaon file to place this against a meaningful peer group, so we don't.
Other critical care medicine in Lincoln
- Mary CammackLincoln$645
- Tammy WichmanOmaha$12K
- Niraj YadavGrand Island$5K
- Camille KantaiNorfolk$4K
- Fernando YepesKearney$2K
- Jason LambrechtOmaha$1K
- Steven LiscoOmaha$551
- Andrew PattersonOmaha$454
- Dominique SamuelOmaha$393
- Sabin BistaOmaha$370
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.